Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Cash from Financing Activities (2016 - 2025)

Amn Healthcare Services (AMN) has disclosed Cash from Financing Activities for 16 consecutive years, with -$83.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 4.19% year-over-year to -$83.2 million, compared with a TTM value of -$295.9 million through Dec 2025, down 14.05%, and an annual FY2025 reading of -$295.9 million, down 14.05% over the prior year.
  • Cash from Financing Activities was -$83.2 million for Q4 2025 at Amn Healthcare Services, down from -$71.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $363.5 million in Q4 2023 and bottomed at -$237.5 million in Q1 2022.
  • Average Cash from Financing Activities over 5 years is -$58.6 million, with a median of -$66.2 million recorded in 2025.
  • The sharpest move saw Cash from Financing Activities plummeted 4711.51% in 2022, then skyrocketed 306.13% in 2023.
  • Year by year, Cash from Financing Activities stood at -$3.7 million in 2021, then tumbled by 4711.51% to -$176.3 million in 2022, then surged by 306.13% to $363.5 million in 2023, then plummeted by 121.98% to -$79.9 million in 2024, then dropped by 4.19% to -$83.2 million in 2025.
  • Business Quant data shows Cash from Financing Activities for AMN at -$83.2 million in Q4 2025, -$71.2 million in Q3 2025, and -$80.2 million in Q2 2025.